bradykinin, des-arg(9)- has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Roche, JA; Roche, R | 1 |
Danser, AHJ; de Maat, S; de Mast, Q; Maas, C; van de Veerdonk, FL | 1 |
Burckhardt, BB; Gangnus, T | 1 |
Aalikhani, M; Alikhani, M; Javadi, A | 1 |
1 review(s) available for bradykinin, des-arg(9)- and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Betacoronavirus; Bradykinin; Chick Embryo; Coronavirus Infections; COVID-19; Disease Models, Animal; Humans; Kininogens; Mice; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pulmonary Edema; Renin-Angiotensin System; SARS-CoV-2 | 2020 |
3 other study(ies) available for bradykinin, des-arg(9)- and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications.
Topics: Angiotensin-Converting Enzyme 2; Betacoronavirus; Bradykinin; Bradykinin B2 Receptor Antagonists; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dyspnea; Feedback, Physiological; Humans; Inflammation; Models, Biological; Off-Label Use; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Bradykinin; Receptors, Virus; SARS-CoV-2 | 2020 |
Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system.
Topics: Bradykinin; Chromatography, Liquid; COVID-19; Humans; Kallidin; Kallikrein-Kinin System; Limit of Detection; Peptide Fragments; Tandem Mass Spectrometry | 2021 |
Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Bradykinin; Chemokine CXCL5; COVID-19; Cytokine Release Syndrome; Humans; Neutrophils; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Interleukin-8B; SARS-CoV-2 | 2021 |